Evidence map›Paper›PMID 29471082›Full record

ArticleJournal of psychiatric research2018

Anhedonic behavior and γ-amino butyric acid during a sensitive period in female rats exposed to early adversity.

Jodi L Lukkes, Shirisha Meda, Kevin J Norman, Susan L Andersen

Open access · greenAbstract read
In one paragraph

Article in Journal of psychiatric research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jodi L LukkesLaboratory for Developmental Neuropharmacology, McLean Hospital, MA, 02478, United States; Harvard Medical School, United States.
Shirisha MedaLaboratory for Developmental Neuropharmacology, McLean Hospital, MA, 02478, United States.
Kevin J NormanLaboratory for Developmental Neuropharmacology, McLean Hospital, MA, 02478, United States.
Susan L AndersenLaboratory for Developmental Neuropharmacology, McLean Hospital, MA, 02478, United States; Harvard Medical School, United States. Electronic address: sandersen@mclean.harvard.edu.
McLean Hospital · USHarvard University · US

Funding

Early Drug Exposure and Drug Reward MechanismsR01DA015403 · NIDA · MC LEAN HOSPITAL (BELMONT, MA) · PI ANDERSEN, SUSAN L · 2003 to 2014
$2.6M
Sensitive periods, development, and substance abuseR01DA026485 · NIDA · MCLEAN HOSPITAL · PI ANDERSEN, SUSAN L · 2011 to 2015
$1.8M
NIDA NIH HHS R01 DA015403NIDA NIH HHS R01 DA026485
6 · The paper itself

Abstract

Early life adversity increases depressive behavior that emerges during adolescence. Sensitive periods have been associated with fewer GABAergic interneurons, especially parvalbumin (PV), brain derived growth factor, and its receptor, TrkB. Here, maternal separation (MS) and social isolation (ISO) were used to establish a sensitive period for anhedonic depression using the learned helplessness (LH) paradigm. Female Sprague-Dawley rat pups underwent MS for 4-h/day or received typical care (CON) between postnatal days 2-20; for the ISO condition, separate cohorts were individually housed between days 20-40 or served as controls (CON2). Anhedonia was defined by dichotomizing subjects into two groups based on one standard deviation of the mean number of escapes for the CON group (<14). This approach categorized 22% of CON subjects and 44% of MS subjects as anhedonic (p < 0.05), similar to the prevalence in maltreated human populations. Only 12.5% of ISO rats met criterion versus 28.5% in CON2 rats. Levels of PV and TrkB were reduced in the amygdala and prelimbic prefrontal cortex (PFC) in MS rats with <14 escapes, but elevated in behaviorally resilient MS rats (>13 escapes). The number of escapes in MS subjects significantly correlated with PV and TrkB levels (PFC: r = 0.93 and 0.91 and amygdala: r = 0.63 and 0.81, respectively; n = 9), but not in CON/ISO/CON2 subjects. Calretinin, but not calbindin, was elevated in the amygdala of MS subjects. These data suggest that low levels of PV and TrkB double the risk for anhedonia in females with an MS history compared to normal adolescent females.

Indexed as

Maternal DeprivationResilience, PsychologicalAmygdalaAnhedoniaAnimalsBehavior, AnimalDepressionDisease Models, AnimalFemaleHelplessness, LearnedParvalbuminsPrefrontal CortexRatsRats, Sprague-DawleyReceptor, trkBSocial IsolationNtrk2 protein, ratParvalbuminsReceptor, trkBAdolescenceAmygdalaDepressionHelplessnessParvalbuminPrefrontal cortexsensitive period

Identifiers

PMID29471082
PMCPMC6295145
OpenAlexW2789444816

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.